Goldman Sachs
MSACU

Goldman Sachs’s Medicus Sciences Acquisition Corp. Unit MSACU Stock Holding History

Goldman Sachs’s Portfolio MSACU Stock Details MSACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,600
Closed -$124K – 6831
2021
Q1 		$124K Buy
+12,600
New +$128K ﹤0.01% 5781

Other funds holding MSACU

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Goldman Sachs's MSACU Position: Q2 2021 in Review

Goldman Sachs sold out of Medicus Sciences Acquisition Corp. Unit (MSACU) in Q2 2021, closing a stake of 12,600 shares — an estimated $124K sold.

Goldman Sachs first reported a position in MSACU in Q1 2021 and held it in 1 quarter. The position peaked at $124K in Q1 2021. 1 fund tracked by Wall St. Rank holds MSACU as of Q2 2021.

  • Goldman Sachs reported no remaining Medicus Sciences Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 12,600 Medicus Sciences Acquisition Corp. Unit shares in Q2 2021, an estimated $124K.
  • Goldman Sachs first reported a position in Medicus Sciences Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
  • Goldman Sachs's Medicus Sciences Acquisition Corp. Unit position peaked at $124K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Unit as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.